Piper Jaffray Raises Price Target on Cantel Medical (CMN) Following 3Q15
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Cantel Medical Reports Results For The Third Quarter Ended April 30, 2015
June 9, 2015 8:01 AM EDTLITTLE FALLS, N.J., June 9, 2015 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMN) reported US GAAP net income of $12,356,000, or $0.30 per diluted share, on an 18% increase in sales to a record $141,508,000 for the third quarter ended April 30, 2015. This compares with net income of $10,249,000, or $0.25 per diluted share, on sales of $120,058,000 for the third quarter ended April 30, 2014. For the nine months ended April 30, 2015, the Company reported US GAAP net income of $34,680,000, or $0.83 per diluted share, on a 16% increase in sales to a record $413,749,000. This compares with net income of $32,560,000 or $0.79 per diluted... More
